Director at QuidelOrtho (QDEL) receives 1,407 shares from RSU release
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
QuidelOrtho Corp director Ann D. Rhoads reported routine equity compensation activity. She received a total of 1,407 shares of common stock on May 22, 2026 through the release of previously reported restricted stock units.
Footnotes state these restricted stock units each convert into one share of common stock and that their release was deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors, occurring according to her elected deferral schedule. The filing shows no open‑market purchases or sales, only grants and conversions of equity awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
1,407 shares exercised/converted
Mixed
4 txns
Insider
RHOADS ANN D
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (Converted) | 1,173 | $0.00 | -- |
| Exercise | Restricted Stock Units (Premium) | 234 | $0.00 | -- |
| Grant/Award | Common Stock | 1,173 | $0.00 | -- |
| Grant/Award | Common Stock | 234 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units (Converted) — 0 shares (Direct, null);
Restricted Stock Units (Premium) — 0 shares (Direct, null);
Common Stock — 16,194 shares (Direct, null)
Footnotes (1)
- Reflects release of restricted stock units that were previously reported on a Form 4. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Key Figures
Common shares from RSU release: 1,407 shares
First award share amount: 234 shares
Second award share amount: 1,173 shares
+1 more
4 metrics
Common shares from RSU release
1,407 shares
Total common stock received on May 22, 2026
First award share amount
234 shares
Common Stock credited at $0.00 per share
Second award share amount
1,173 shares
Common Stock credited at $0.00 per share
Derivative exercises
1,407 shares
Exercise of restricted stock units into common shares
Key Terms
Restricted Stock Units, deferred compensation program, non-employee directors, Exercise or conversion of derivative security
4 terms
Restricted Stock Units financial
"Reflects release of restricted stock units that were previously reported on a Form 4."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred compensation program financial
"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors"
non-employee directors financial
"deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors"
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
FAQ
What insider transaction did QuidelOrtho (QDEL) report for Ann D. Rhoads?
QuidelOrtho reported that director Ann D. Rhoads received equity compensation. She acquired 1,407 common shares through the release and conversion of previously reported restricted stock units on May 22, 2026, with no open‑market buying or selling involved.
What role did restricted stock units play in the QuidelOrtho (QDEL) Form 4?
The Form 4 centers on restricted stock units converting into common stock. Footnotes explain each unit equals one QuidelOrtho common share, and the reported transactions reflect the release of these units that had been reported previously on an earlier Form 4.
Was the QuidelOrtho (QDEL) director transaction linked to a deferred compensation program?
Yes. Footnotes state the restricted stock unit release was deferred under QuidelOrtho’s deferred compensation program for participating non‑employee directors and occurred according to Ann D. Rhoads’ elected deferral schedule, indicating a pre‑set compensation timing choice.